CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to discover new anti-infective drugs targeting specific pathogens by exploring uncharted biochemical pathways. It focuses on developing small-molecule inhibitors for diseases like tuberculosis and MRSA, leveraging innovative hit-identification strategies to overcome existing drug development challenge…
Given the rapid emergence of anti-infective resistance, drugs with a novel mode of action are urgently needed.
Because of an exhaustion of existing strategies, a low return on investment and the fact that anti-infectives are difficult to develop (e.g., crossing the peculiar cell wall of Mycobacterium tuberculosis), promising un(der)explored targets and unconventional hit-identification strategies are needed.I have selected three anti-infective targets based on their biochemical context for which…
HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
